2001
DOI: 10.1023/a:1010406927727
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
11
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 0 publications
1
11
0
Order By: Relevance
“…The preparation and activation of the Pd-containing anion exchangers, the study methods, the hydrogenation procedure, and the isolation, purification, and identification of reaction products were described before [2,3].…”
Section: Experimental Partmentioning
confidence: 99%
“…The preparation and activation of the Pd-containing anion exchangers, the study methods, the hydrogenation procedure, and the isolation, purification, and identification of reaction products were described before [2,3].…”
Section: Experimental Partmentioning
confidence: 99%
“…Methods used for the preparation of catalysts, reductive acylation process, and the analysis of reaction mixtures are described elsewhere [7]. 4-Acetamidophenol (paracetamol).…”
Section: Experimental Partmentioning
confidence: 99%
“…This behavior is probably explained by a higher selectivity of the latter in the reaction of hydrogenation of nitro compounds [3,4] and by the catalytic activity of free functional groups of anion-exchange resins in the acylation of compound IV formed in situ. In addition, the organic synthesis is frequently accompanied by a rapid poisoning of Pd/C [5], whereas metal-containing polymers practically never lose their activity and selectivity [6,7].…”
mentioning
confidence: 99%
“…Our accumulated experience in the synthesis of medicinal substances containing amino groups by hydrogenation [1,2], hydroamination [3], and reductive acetylation [4] on palladium catalysts allows us to obtain target products at high yield. We have investigated the potential of the catalytic synthesis of an important group of pharmaceutical agentslocal anesthetics [5]: lidocaine (a-diethylamino-2,6-dimethylacetanilide, I), bipuvacaine (1-butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide, II), mepivacaine (1-methyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide, III), trimecaine (a-diethylamino-2,4,6-trimethylacetanilide, IV), and pyromecaine (1-butyl-2,4,6-trimethyl-2-pyrrolidinecarboxamide, V).…”
mentioning
confidence: 99%
“…The resulting a-picolinic acid 2,6-xylidide is methylated to form compound III by hydroamination of formalde- 1 hyde with a-picolinic acid 2,6-xylidide on Pd\C. Another method [9] produces III by the interaction of 1-methylpiperidine-2-carboxylic acid ethyl ester with 2,6-dimethylaniline magnesium bromide previously prepared from VI and ethyl magnesium bromide.…”
mentioning
confidence: 99%